| February
7, 2003
Little
Rock ---
The Arkansas Department of Health (ADH) received
a total of 8,000 doses of smallpox vaccine Thursday, February
6, 2003, in preparation for the voluntary vaccination of
public health and hospital teams across the state.
The Centers for Disease Control
and Prevention (CDC) began offering shipment of the vaccine in
late January to individual states upon request. Arkansas
placed its vaccine order January 29, requesting delivery for
this week.
Vaccine shipments were offered
following a directive from the U.S. Department of Health and
Human Services and the White House to implement Phase I of the
smallpox pre-event plan. The federal directive was issued
based on concerns that terrorists might use smallpox as a
bioterroristic weapon. Naturally occurring smallpox was
eradicated from the world in the 1970s.
The voluntary vaccinations will
begin with ADH Director Fay Boozman, MD, and members of the
statewide public health smallpox response team, on Wednesday,
February 19, at 1:15 p.m. The vaccinations will be
administered in the ADH auditorium at 4815 West Markham.
Twenty-two clinics statewide will begin voluntary vaccinations
of regional public health and hospital response teams during
the week of February 24.
If an actual smallpox outbreak
should occur, the public health response teams vaccinated in
Phase I would respond by either providing vaccine,
investigating potential cases or providing care to those
infected.
“Phase
I will prepare us to vaccinate and care for smallpox patients
in the unlikely event that smallpox would occur in the United
States,” Donnie Smith, ADH Bioterrorism Preparedness Team
leader, said. “Vaccination within three days of exposure
will also prevent or reduce the severity of the disease in
most people. Vaccination four to seven days after exposure
also will offer some protection from the disease.”
There
are no indications that the threat of smallpox is imminent.
Phase I is strictly a precautionary measure.
“By vaccinating volunteers
who would be initially called upon to respond to a smallpox
outbreak, we are strengthening Arkansas’ ability to protect
the health of the public,” Dr. Boozman said. “The vaccine
is not recommended for the general public at this time since
there is no known threat of smallpox.”
ADH has asked 79 acute care
hospitals statewide to consider participating in the plan but
will not know how many hospitals will participate until
February 14.
“This
is a voluntary program, and we respect the decision of some
hospitals not to vaccinate during Phase I,” Smith said.
“We are not concerned about ‘getting enough people
vaccinated.’ Our goal is to get a limited number of people
vaccinated during Phase I so we will have a core group of
responders who can go into action immediately in the event of
a smallpox attack. We believe we will be able to accomplish
that.”
The
CDC Public Response Service hotline with vital information for
Arkansans is available at 888-246-2675 (English), 888-246-2857
(Español), or 866-874-2646 (TTY).
---30---
MEDIA
ALERT REMINDER
ADH will
conduct a media briefing Thursday, February 13, 2003,
9:30-11:30 a.m. in the ADH auditorium at 4815 West Markham
St., Little Rock, in preparation for implementation of
Phase I of the Smallpox Pre-Event Plan. Following is the
briefing agenda:
- Opening
comments by Ann Wright, ADH external communications media
director
- Brief
explanation of handouts by Bob Alvey, risk communications
specialist
- “Arkansas
Pre-Event Smallpox Plan – Phase I,” by Donnie Smith
Bioterrorism Preparedness Team Leader
- “Smallpox
– The Disease” by Dr. William Mason, MD
- “The
Smallpox Vaccine” by Dr. Sandra Snow, MD
- Smallpox
vaccine photo opportunity
- “Smallpox
Clinic Operation Plan”
- February
19 press conference & first smallpox vaccinations
overview
- Meeting
Media Needs – A partnership between the media and ADH
Media
representatives are encouraged to attend and asked to RSVP by
close of business on Monday, February 10. Please RSVP by
either calling Pauline Rowbottom at 501-661-2984 or emailing
her at prowbottom@healthyarkansas.com.
|